Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34)

Key Dates

• October 4, 2022 - NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional). See NOFO RFA-DA-23-062 

National Institute on Drug Abuse (NIDA)

The National Institute on Drug Abuse (NIDA) intends to promote the reissue of an initiative by publishing a notice of funding opportunity (NOFO) to solicit applications for research on NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. 

The NOFO is expected to be published in Summer 2025 with an expected application due date in Winter 2025.

This NOFO will utilize the R34 activity code. Details of the planned NOFO are provided below.

This Notice encourages investigators with expertise and insights into the area of HIV and substance use disparities to begin to consider applying for this reissue.

The purpose of this initiative is to stimulate observational or intervention research on structural factors, organizational practices, policies, and other social, cultural, and contextual influences that lead to inequities at the intersection of HIV and substance use among underserved racial and/or ethnic minority populations affected by persistent HIV disparities. Research that addresses the multiple dimensions of individuals’ identity (e.g., race, ethnicity, gender, sexual orientation, gender identity) and social systems as they intersect with one another is encouraged.

Research Objectives

This initiative will support innovative and transformative research to inform efforts to address persistent inequities in HIV prevention, diagnosis, and treatment among underserved racial and/or ethnic minority populations. All projects should address social, cultural, and structural factors potentially driving inequities. Research that addresses intersectional sexual and gender minority populations are also encouraged. Areas of research can include epidemiology, prevention, and treatment services research addressing topics such as stigma, cultural competence, accessibility, acceptability, retention, mistrust/trustworthiness, and financing. The proposed research should be well-supported by preliminary data, clinical and/or preclinical studies, or other peer-reviewed studies. Proposed studies can be:

1) observational studies, providing a deeper understanding of how social, cultural, policy and structural factors interact to perpetuate or ameliorate health inequities in HIV and substance use outcomes for racial and/or ethnic minority persons and other persons with disproportionate burden of HIV disease, or

2) intervention studies that test novel strategies that focus on social, structural, policy and cultural factors in order to reduce health disparities and lead to equity in HIV and substance use outcomes for populations affected by persistent disparities. 

Funding Information

Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization
Eligible Agencies of the Federal Government

Applications are not being solicited at this time. 

Inquiries

Please direct all inquiries to:

Sheba K. Dunston, EdD
National Institute on Drug Abuse (NIDA)
Telephone: (301) 402-1526
Email: [email protected]